Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CRD-100 by Curadev Pharma for Angiosarcoma: Likelihood of Approval
CRD-100 is under clinical development by Curadev Pharma and currently in Phase I for Angiosarcoma. According to GlobalData, Phase I...
CRD-100 by Curadev Pharma for Bone Sarcoma: Likelihood of Approval
CRD-100 is under clinical development by Curadev Pharma and currently in Phase I for Bone Sarcoma. According to GlobalData, Phase...
CRD-100 by Curadev Pharma for Fibrosarcoma: Likelihood of Approval
CRD-100 is under clinical development by Curadev Pharma and currently in Phase I for Fibrosarcoma. According to GlobalData, Phase I...
CRD-100 by Curadev Pharma for Merkel Cell Carcinoma: Likelihood of Approval
CRD-100 is under clinical development by Curadev Pharma and currently in Phase I for Merkel Cell Carcinoma. According to GlobalData,...